Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT SUMATRIPTAN | 100MG | TABLET | Resolved | 2019-08-29 | 2020-07-10 | 92684 |
| ACT TEMOZOLOMIDE | 5MG | CAPSULE | Resolved | 2019-10-31 | 2020-07-09 | 97584 |
| ACT TEMOZOLOMIDE | 20MG | CAPSULE | Resolved | 2020-01-30 | 2020-07-09 | 104922 |
| ACT TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2020-01-30 | 2020-06-18 | 104927 |
| ACT TEMOZOLOMIDE | 5MG | CAPSULE | Resolved | 2021-01-22 | 2021-06-03 | 132279 |
| ACT TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2021-09-30 | 2021-10-21 | 146434 |
| ACT TEMOZOLOMIDE | 100MG | CAPSULE | Resolved | 2020-08-27 | 2020-09-10 | 123093 |
| ACT TEMOZOLOMIDE | 100MG | CAPSULE | Resolved | 2020-09-10 | 2020-11-07 | 124085 |
| ACT TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2020-09-25 | 2020-11-07 | 125028 |
| ACT TEMOZOLOMIDE | 20MG | CAPSULE | Resolved | 2020-10-01 | 2020-11-07 | 125512 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2020-07-23 | 2020-09-24 | 120905 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2023-02-09 | 2023-07-05 | 184195 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2020-04-10 | 2023-10-03 | 111874 |
| ACT TERBINAFINE | 250MG | TABLET | Actual shortage | 2024-10-11 | 2025-01-30 | 240028 |
| ACT TERBINAFINE | 250MG | TABLET | Actual shortage | 2024-10-11 | 2025-04-28 | 240037 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2025-01-30 | 2025-01-30 | 249182 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2023-06-19 | 2023-08-17 | 195629 |
| AERMONY RESPICLICK | 55MCG | POWDER (METERED DOSE) | Resolved | 2022-12-01 | 2023-01-18 | 176791 |
| AERMONY RESPICLICK | 232MCG | POWDER (METERED DOSE) | Resolved | 2022-12-01 | 2023-04-28 | 176860 |
| ALERTEC | 100MG | TABLET | Resolved | 2022-08-18 | 2022-09-23 | 167165 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
| TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81371 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Discontinued | 2025-03-20 | 2025-03-20 | 253186 |
| TEVA-FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256091 |
| TEVA-FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256137 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |